glp-1 and dpp-4 inhibitors The Role of GLP-1, DPP-4, SGLT-2 in Diabetes Management The effect of DPP-4 inhibitors,

Ipamorelin (Growth Hormone Releasing Peptide - GHRP): This peptide is a highly selective agonist that signals the pituitary to actually release the GH in a series of natural pulses, similar to how the body releases GH during deep sleep

The half-life of this molecule is 5 days [18]

The antibodies used for the immunoblot assays were: GCLC (Santa Cruz Biotech, #sc-390811), NQO1 (Sigma Prestige Antibodies, HPA007308), ACTIN (Sigma, A1978), NRF2 (Cell Signaling Technology, #12721), NRF1 (Cell Signaling Technology, #8052), YAP/TAZ (Cell Signaling, #8418) 4-HNE (Abcam, #ab46545) and Lamin A/C (Cell Signaling, #4777)

Skin exposed to daily environmental stress

The peptide rapidly normalizes intraocular pressure and preserves the integrity of retinal ganglion cells and optic nerves